Compound ID | 2852
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antivirulence; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Cytochrome bc1 inhibitor |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Propensity to select resistant mutants: | Yes, at 2.17x10^-10 mutation frequency at 5xMIC |
| Description: | Synthetic compound; quinoline-amine; macrophage cytotoxicity at high concentration (selectivity index of 79.8) |
| Institute where first reported: | German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany |
| Year first mentioned: | 2012 |
| Development status: | Experimental |